NCIt definition : Autologous human T-lymphocytes transduced with a recombinant lentiviral vector encoding
a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of an anti-CD22
single chain variable fragment (scFv) derived from the monoclonal antibody (moAb)
971 (m971), and the co-stimulatory domain 4-1BB (CD137) coupled to the zeta chain
of the TCR/CD3 complex (CD3-zeta), with potential immunostimulating and antineoplastic
activities. Upon administration, the anti-CD22-CAR m971-BBz lentiviral vector-transduced
autologous T-lymphocytes CRG-022 express anti-CD22-CAR on their cell surfaces and
bind to the CD22 antigen on tumor cell surfaces. Subsequently, CD22-expressing tumor
cells are lysed. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein,
is expressed on malignant B-cells. m971 binds to a membrane proximal epitope on CD22
and has a higher binding affinity compared to other anti-CD22 moAb.;